Morningstar

Currax Announces ObesityWeek® Data Showing that CONTRAVE® Helps Curb Cravings and Offers Marked Effectiveness in Certain Populations with Obesity

Data to be shared during an ObesityWeek press conference include four of seven presentations supporting CONTRAVE and its utility in helping people lose weight BRENTWOOD, Tenn., Nov. 4, 2025 ...
MarketWatch

Currax Pharmaceuticals to Spotlight New Research at ObesityWeek(R) 2025 Highlighting Craving Control, Behavioral Adherence, and Subpopulation Outcomes with CONTRAVE(R)

The MarketWatch News Department was not involved in the creation of this content. Data to be shared during an ObesityWeek press conference includes four of seven data presentations supporting CONTRAVE ...
Berkshire Eagle

Currax Announces ObesityWeek® Data Showing that CONTRAVE® Helps Curb Cravings and Offers Marked Effectiveness in Certain Populations with Obesity

When compared to placebo, patients treated with CONTRAVE showed significant improvements in positive mood, reduced cravings for savory foods, and overall greater control of cravings. The study further ...
WWLP-22News

Currax Pharmaceuticals to Spotlight New Research at ObesityWeek® 2025 Highlighting Craving Control, Behavioral Adherence, and Subpopulation Outcomes with CONTRAVE®

Data to be shared during an ObesityWeek press conference includes four of seven data presentations supporting CONTRAVE and its utility in helping people lose weight BRENTWOOD, Tenn., Oct. 28, 2025 ...